Table 5.
Participants Treated with High Daily Morphine-Equivalent Dose (>200 mg/d) During the Study
| Variable | MED ≤200 mg/d | MED >200 mg/d |
|---|---|---|
| Experimental groupa | ||
| Baseline | 71.4 (15) | 28.6 (6) |
| 8-wk follow-up | 80.0 (16) | 20.0 (4) |
| 26-wk follow-up | 80.0 (16) | 20.0 (4) |
| Control groupb | ||
| Baseline | 78.6 (11) | 21.4 (3) |
| 8-wk follow-up | 71.4 (10) | 28.6 (4) |
| 26-wk follow-up | 76.9 (10) | 23.1 (3) |
Values are expressed as percentage (number) of participants.
a
Data provided by 21, 20, and 20 experimental participants at baseline, 8 weeks, and 26 weeks, respectively.
b
Data provided by 14, 14, and 13 control participants at baseline, 8 weeks, and 26 weeks, respectively.
MED, morphine-equivalent dose.